Brief: Cyclo Therapeutics Provides Clinical Program Update And Highlights Recent Achievements
11/01/2023 13:40
Cyclo Therapeutics Inc CYTH.O :
* CYCLO THERAPEUTICS PROVIDES CLINICAL PROGRAM UPDATE AND
HIGHLIGHTS RECENT ACHIEVEMENTS
* CYCLO THERAPEUTICS - PATIENT ENROLLMENT AND DOSING IN
PHASE 2B
STUDY OF TRAPPSOL(®) CYCLO™ FOR TREATMENT OF EARLY ALZHEIMER'S
DISEASE (AD) UNDERWAY
* CYCLO THERAPEUTICS - CONTINUED PROGRESS IN ONGOING
PIVOTAL
PHASE 3 GLOBAL STUDY ON TRACK TO COMPLETE ENROLLMENT BY YEAR END
2023
Source text for Eikon: ID:nBw43GCXka
Further company coverage: CYTH.O
Recent news on Cyclo Therapeutics
See all newsBrief: Rafael Holdings Completes Merger With Cyclo Therapeutics Following Shareholder Approvals
Cyclo Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Cyclo Therapeutics Inc Issues $2.5 Million Convertible Promissory Note To Rafael Holdings
U.S. STOCKS ON THE MOVE-McDonald, Uber, SolarWinds
Cyclo Therapeutics jumps on prelim late-stage data of genetic disorder drug